SCOPUS 정보 검색 플랫폼

International Journal of Antimicrobial Agents

Volumn 19, Issue 2, 2002, Pages 95-103

Piperacillin 2 g/tazobactam 0.5 g is as effective as imipenem 0.5 g/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections

(3) Naber, Kurt G a Savov, Orlin a Salmen, Hans C b

a Urologische Klinik (Germany)

b Wyeth Pharma GmbH (Germany)

Author keywords

Acylamino penicillin; Antibacterial; Imipenem cilastatin; Piperacillin tazobactam; Pyelonephritis; Urinary tract infection

Indexed keywords

CILASTATIN PLUS IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENTEROBACTER CLOACAE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FATIGUE; FEMALE; FEVER; FOLLOW UP; GRAM POSITIVE COCCI; HALLUCINATION; HEADACHE; HUMAN; INSOMNIA; KLEBSIELLA PNEUMONIAE; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; MORTALITY; MULTICENTER STUDY; MUSCLE HYPERTONIA; NAUSEA; PAIN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; PYELONEPHRITIS; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS; TACHYCARDIA; TREATMENT OUTCOME; URINALYSIS; URINARY TRACT INFECTION; VERTIGO; VULVOVAGINITIS;

ADOLESCENT; ADULT; AGED; CILASTATIN; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMIPENEM; MALE; MIDDLE AGED; PENICILLANIC ACID; PENICILLINS; PIPERACILLIN; PYELONEPHRITIS; SAMPLE SIZE; THIENAMYCINS; URINARY TRACT INFECTIONS;

EID: 0036180913 PISSN: 09248579 EISSN: None Source Type: Journal
DOI: 10.1016/S0924-8579(01)00481-2 Document Type: Article

Times cited : (41)

References (48)

1
- 0002915790
- Nosocomial urinary tract infections
- Bennett J.V., Brachmann P.S. (Eds.), Hospital infections, Boston: Little, Brown and Co
- (1992) , pp. 597-610
- Stamm, W.E.¹

2
- 0008370277
- Surveillance of nosocomial infections
- Bennett J.V., Brachmann (Eds.), Hospital infections, Boston: Little, Brown and Co
- (1992) , pp. 79-108
- Haley, R.W.¹

3
- 0028020670
- Management of bacterial urinary tract infections in adults
- (1994) Ann. Pharmacother. , vol.28 , pp. 1264-1272
- Hatton, J.¹ Hughes, M.² Raymond, C.M.³

4
- 0029761949
- DMSA renal scans in adults with acute pyelonephritis
- (1996) Clin. Nephrol. , vol.46 , pp. 99-104
- Bailey, R.R.¹ Lynn, K.L.² Robson, R.A.³

5
- 0012897232
- Basel: Karger
- (1997) Management of acute uncomplicated pyelonephritis , vol.1 , pp. 8-13
- Nicolle, L.E.¹

6
- 0008418735
- Uncomplicated acute pyelonephritis
- Bergan T.E. (Ed.), Basel: Karger
- (1993) Urinary tract infections , vol.1 , pp. 14-18
- Bailey, R.R.¹

7
- 0026599493
- Renal ultrasonographic correlates of acute pyelonephritis
- (1992) Clin. Infect. Dis. , vol.14 , pp. 15-22
- Johnson, J.R.¹ Vincent, L.M.² Wang, K.³

8
- 0032898726
- Piperacillin/tazobactam-an updated review of its use in the treatment of bacterial infections
- (1999) Drugs , vol.57 , pp. 805-843
- Perry, M.P.¹ Markham, A.²

9
- 0020375776
- Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins
- (1982) Ann. Int. Med. , vol.97 , pp. 755-760
- Eliopoulos, G.M.¹ Moellering, R.C.²

10
- 0020508560
- Statistical comparison of the antibacterial activities of broad-spectrum penicillins against Gram-negative bacilli
- (1983) Antimicrob. Agents Chemother. , vol.24 , pp. 156-162
- Fass, R.J.¹

11
- 0008493805
- Methodische Besonderheiten der Testung von Tazobactam/Piperacillin (Tazobac®)
- (1992) Fortschr. Antimikrob. Antineoplast. Chemother. , vol.11 , pp. 1-10
- Grimm, H.¹

12
- 4243620585
- Antibiotikatherapie von Patienten mit akuter Pyelonephritis und/oder komplizierten Harnwegsinfektionen mit Tazobactam/Piperacillin (Tazobac®): eine multizentrische Studie
- (1992) Fortschr. Antimikrob. Antineoplast. Chemother. , vol.11 , pp. 547-558
- Naber, K.G.¹

13
- 0030045596
- Piperacillin/tazobactam: a critical review of the evolving clinical literature
- (1996) Clin. Infect. Dis. , vol.22 , pp. 107-123
- Sanders, W.E.¹ Sanders, C.C.²

14
- 0030464630
- Piperacillin/tazobactam: antibiotic profile
- (1996) Antiinf. Drugs Chemother. , vol.14 , pp. 187-199
- Rosenstil, N.A.¹ Grimm, H.²

15
- 0027408367
- Susceptibility survey of piperacillin alone and in the presence of tazobactam
- (1993) J. Antimicrob. Ther. Suppl. A , vol.31 , pp. 23-28
- Acar, J.F.¹ Goldstein, F.W.² Kitzis, D.³

16
- 0028316359
- Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential
- (1994) Drugs , vol.47 , pp. 506-535
- Bryson, H.M.¹ Brogden, R.N.²

17
- 0026487036
- Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections
- (1992) Antimicrob. Agents Chemother. , vol.36 , pp. 2766-2773
- Brismar, B.¹ Malmborg, A.S.² Tunevall, G.³

18
- 0028596132
- Piperacillin/tazobactam in the treatment of polymicrobial infections
- (1994) Intens. Care Med. , vol.20 , pp. 27-34
- Gorbach, S.L.¹

19
- 0027466012
- Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections
- (1993) Surg. Gynecol. Obs. , vol.176 , pp. 255-261
- Niinikoski, J.¹ Havia, T.² Alhava, E.³

20
- 0028579709
- The treatment of severe intra-abdominal infections: the role of piperacillin/tazobactam
- (1994) Intens. Care Med. , vol.20 , pp. 35-38
- Nord, C.E.¹

21
- 0027265763
- Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection
- (1993) Am. J. Surg. , vol.59 , pp. 598-605
- Polk, H.C.¹ Fink, M.P.² Laverdiere, M.³

22
- 0028589111
- Piperacillin/tazobactam in complicated urinary tract infections
- (1994) Intens. Care Med. , vol.20 , pp. 39-42
- Nowé, P.¹

23
- 0032793753
- Antibiotikatherapie bei urologischen Infektionen
- (1999) Klinikarzt , vol.28 , pp. 16-18
- Bornkessel, B.¹

24
- 0029872212
- Piperacillin/tazobactam in the treatment of hospitalized patients with urinary tract infections: an open non-comparative and multicentered trial
- (1996) J. Chemother. , vol.8 , pp. 122-129
- Sifuentes-Osornio¹

25
- 0028209175
- Penetration of piperacillin/tazobactam into cancellous and cortical bone tissues
- (1994) Antiinf. Agents Chemother. , vol.38 , pp. 905-907
- Incavo, S.J.¹ Ronchetti, P.J.² Choi, J.H.³ Wu, H.⁴ Sörgel, F.⁵

26
- 0008509661
- Therapie von Knochen- und Gelenkinfektionen mit Tazobactam/Piperacillin (Tazobac®)
- (1992) Fortschr. Antimikr. Antineopl. Chemoth. , vol.11 , pp. 525-534
- Tassler, H.¹

27
- 0033000046
- Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely ill neutropenic patients
- (1999) Supp. Care Cancer , vol.7 , pp. 89-94
- Marie, J.P.¹

28
- 0031819313
- Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients
- (1998) Supp. Care Cancer , vol.6 , pp. 402-409
- Hess, U.¹

29
- 0008474287
- Del Favero A. Double-blind, randomized clinical trial comparing monotherapy with piperacillin-tazobactam vs. piperacillin-tazobactam plus amikacin as empiric therapy for febrile neutropenic cancer patients. Abstract 1092, Thirty-Ninth ICAAC, San Francisco, 1999.

30
- 0008454881
- Glasmacher A. A randomized comparison of piperacillin-tazobactam versus ceftriaxone and gentamicin in 172 severely neutropenic patients with hematologic malignancies. Abstract 1090, Thirty-Ninth ICAAC, San Francisco, 1999.

31
- 0031724015
- Prospective randomized comparison of imipenem/cilastatin vs. piperacillin/tazobactam in nosocomial pneumonia or peritonitis
- (1998) Antimicrob. Agents Chemother. , vol.42 , pp. 2966-2972
- Jaccard, C.¹ Troillet, S.² Harbarth, G.³

32
- 0033065559
- Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin for the treatment of patients with nosocomial respiratory tract infections
- (1999) J. Antimicrob. Chemother. , vol.43 , pp. 389-397
- Joshi, M.¹ Bernstein, J.² Solomkin, J.³ Wester, B.⁴ Kuye, O.⁵

33
- 0027217165
- Erregerempfindlichkeit gegen Tazobactam/Piperacillin bei komplizierten und/oder im Krankenhaus erworbenen Harnwegsinfektionen
- (1993) Fortschr. Antimikrob. Antineoplast. Chemother. , vol.11 , pp. 33-37
- Naber, K.G.¹ Grimm, H.² Witte, W.³

34
- 0008432083
- EMEA-Guideline. Note for guidance on evaluation of new anti-bacterial medicinal products (CPMP/EWP/558/95).

35
- 15444338513
- Clinical trials of antibacterial agents: a practical guide to design and analysis
- (1998) Antimicrob. Chemother. , vol.41 , pp. 467-480
- Smith, C.¹ Burley, C.² Ireson, M.³

36
- 0008431720
- ICH-Guideline. Statistical principles for clinical trials (ICH E9, final signed off, 5 February, 1998).

37
- 0008514578
- General guidelines for the evaluation of new anti-infective drugs for the treatment of urinary tract infections, Taufkirchen, Germany: The European Society of Clinical Microbiology and Infectious Diseases
- (1993) , pp. 294-310
- Rubin, R.H.¹ Shapiro, E.D.² Andriole, V.T.³ Davis, R.Q.⁴ Stamm, W.E.⁵

38
- 0008472694
- Declaration of Helsinki. Edition Somerset West, Republic of South Africa, October, 1996.

39
- 0008431052
- Gute klinische Praxis (GCP) für die klinische Prüfung von Arzneimitteln in der europäischen Gemeinschaft
- Klinische Arzneimittelprüfungen in der EU, Aulendorf: Editio-Cantor-Verlag
- (1995) , pp. 40-66

40
- 84870692558
- Gesetz über den Verkehr mit Arzneimitteln
- Gesetz über den Verkehr mit Arzneimitteln (AMG), Aulendorf: Editio-Cantor-Verlag
- (1994)

41
- 24544446436
- General guidelines for the evaluation of new anti-infective drugs for the treatment of urinary tract infections
- Beam T.R. (Ed.), European guidelines for the clinical evaluation of anti-infective drug product, Part E
- (1993) , pp. 101-111
- Finch, R.¹

42
- 0032955831
- Experience with the new guidelines on evaluation of new anti-infective drugs for the treatment of urinary tract infections
- (1999) Int. J. Antimicrob. Agents , vol.11 , pp. 189-196
- Naber, K.G.¹

43
- 0008454883
- DIN: Deutsches Institut für Normung e.V. Methoden zur Empfindlichkeitsprüfung von bakteriellen Krankheitserregern (außer Mykobakterien) gegen Chemotherapeutika. b. DIN 58940, Teil 3. Agar-Diffusionstest. Beuth-Verlag, Berlin, 1998 bzw. a. DIN 58940, Teil 6. Bestimmung der minimalen Hemmkonzentration nach der Agar-Verdünnungsmethode. c. DIN 58940, Teil 4, Beiblatt 1. Liste der Grenzwerte und Tagesdosierungen von Chemotherapeutika sowie Bewertung der minimalen Hemmkonzentration (MHK). Beuth-Verlag, Berlin, 1998.

44
- 0008420362
- NCCLS, National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disc susceptibility tests. 4th ed. Approved Standards, NCCLS Document M2-A4. Villanova, PA: NCCLS, 1990 bzw. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 2nd ed. Approved standard, NCCLS Document M7-A2. Villanova, PA: NCCLS, 1998/National Committee for Clinical Laboratory Standards: Methods for antimicrobial susceptibility testing of anaerobic bacteria. 2nd ed. NCCLS Document M11-A2. Villanova, PA: NCCLS, 1998.

45
- 0008473527
- SAS/STAT®. SAS Institute Inc. Cary, NC, USA, 1990.

46
- 0008472695
- Antibiotikatherapie bei urologischen Infektionen
- (1999) Klinikarzt , vol.25 , pp. 16-19
- Böhm, S.¹

47
- 0032822085
- Drug resistance among clinical isolates of frequently encountered species in central Europe during 1975-1995
- (1999) Infection , vol.27 , Issue.Suppl 2 , pp. 1-8
- Kresken, M.¹ Hafner, D.²

48
- 0008469973
- Parenterale Antibiotika bei Erwachsenen: urogenitale Infektionen
- (1999) Chemother. J. , vol.8 , pp. 25-27
- Vogel, F.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.